EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders

Clinical trial NCT07450391 · RECRUITING

Trial details

NCT number: NCT07450391
Sponsor: Daihong Liu
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epstein-Barr Virus-Associated Lymphoproliferative Disorders EBV-Positive Lymphoma

Start date: 2025-06-01
Primary completion: 2027-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.